Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase I Trial of Periocular Topotecan in Retinoblastoma

This study has been completed.
Sponsor:
Information provided by:
Hospital JP Garrahan
ClinicalTrials.gov Identifier:
NCT00460876
First received: April 13, 2007
Last updated: April 30, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2008
  Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
No publications provided by Hospital JP Garrahan

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):